Volume 3, Issue 3 (2018)                   SJMR 2018, 3(3): 153-157 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saremi A, Mahdizadeh Shahi A, Pooladi A, Shami M, Safavi M. Reproductive Outcomes of Ovarian Hyperstimulation Syndrome (OHSS) in PCO Compare to non-PCO Patients. SJMR 2018; 3 (3) :153-157
URL: http://saremjrm.com/article-1-69-en.html
1- “Sarem Fertility & Infertility Research Center (SAFIR)” and “Sarem Cell Research Center (SCRC)”, Sarem Women’s Hospital, Tehran, Iran
2- Sarem Women’s Hospital, Tehran, Iran , fbehjati@gmail.com
3- Sarem Women’s Hospital, Tehran, Iran
Abstract:   (6488 Views)

Aims: Ovulation induction is one of the main steps in assisted reproductive technology (ART). Ovarian hyperstimulation syndrome (OHSS) is a serious complication of ART. The patients with polycystic ovary (PCO) are at higher risk for OHSS when they are subjected to such techniques. The objective of this study was to investigate the pregnancy outcomes of mild and moderate OHSS in PCO and non-PCO patients.
Materials and Methods: This retrospective cross-sectional study was carried out on 321 OHSS patients candidate for IVF/ICSI based on their medical records in Sarem Women’s Hospital (Tehran, Iran) in a period of two years. The general characteristics of the patients and the parameters related to pregnancy were compared between the group of PCO and non-PCO patients. Data were analyzed by Fisher exact test and T-test using SPSS 13 software.
Findings: A significant difference was found in hospitalization periods between PCO and non-PCO groups (p=0.002). The PCO group showed higher level of OHSS severity compared to the non-PCO group (p=0.0001). The number of transferred embryo had significant difference between PCO and non-PCO groups (p=0.015). There was no significant difference in clinical pregnancy success rate between PCO (11.8%) and non-PCO (14.2%) patients (p=0.602).
Conclusion: In OHSS patients, the overall pregnancy success rate is lower than normal. The PCO background is not a determining factor for the pregnancy success rate in the patients with OHSS. A similar pregnancy success rate can be achieved by longer duration of treatment for OHSS and more number of transmitted embryos in individuals with PCO.

Full-Text [PDF 401 kb]   (2061 Downloads)    
Article Type: Original Research | Subject: Reproduction
Received: 2017/04/25 | Accepted: 2017/10/17 | Published: 2018/11/22

References
1. Kazemi A, Hasanzahraee R. The effect of polycystic ovary syndrome on outcome of assisted reproductive technology in Isfahan Infertility Center in 2003. Iranian J Nursing Midwif Research. 2006;11(1). [Link]
2. Richardson MR. Current perspectives in polycystic ovary syndrome. Am fam physician. 2003;68(4):697-704. [Link] [PMID]
3. Mohiti-Ardekani J, Taarof N. Comparison of leptin blood levels and correlation of leptin with LH and FSH in PCOS patients and normal individuals. SSU J. 2010;17(5):353-7. [Link]
4. Williams T, Mortada R, Porter S. Diagnosis and Treatment of Polycystic Ovary Syndrome. Am fam physician. 2016;94(2):106-13. [Link] [PMID]
5. Nabiuni M, Parivar K, Zeynali B, Karimzadeh L, Sheikholeslami A. Changes in the expression of cyclooxygenase-2 in polycystic ovary syndrome in wistar rats. Tehran Univ Med J. 2011;69(9):537-46. [Link]
6. Saremi A. Textbook of Reproductive Medicine. Sarem Journal of Medicine. 2016;5(17):63-4.
7. Saremi A, Mehdizadeh SA, Shami M, Safavi M. Effect of mannitol therapy protocol on ovarian hyperstimulation syndrome management, comparisonbetween PCO and non-PCO patient's outcome. International J fertil sterlity. 2013;7(1):117. [Link]
8. Saremi A, Namdar khanzadeh M, Shami M, Alaiha F, Pooladi A. The Efficacy of Mannitol Therapy in the Management of Moderate and Severe Forms of Ovarian Hyperstimulation Syndrome: A New Application. Sarem Journal of Medicine. 2012;1(3):9-19.
9. Saremi AT, Shami M, MohammadAliha F, Pooladi A. Use of Mannitol therapy for ovarian hyperstimulation syndrome (ohss) management. Med J Obstet Gynecol. 2017;5(1). [Link]
10. Tummon I, Gavrilova Jordan L, Allemand MC, Session D. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta obstet gynecol Scand. 2005;84(7):611-6. https://doi.org/10.1111/j.0001-6349.2005.00788.x [Link] [DOI:10.1080/j.0001-6349.2005.00788.x] [PMID]
11. Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10(1):32. [Link] [DOI:10.1186/1477-7827-10-32] [PMID] [PMCID]
12. Onofriescu A, Luca A, Bors A, Holicov M, Onofriescu M, Vulpoi C. Principles of diagnosis and management in the ovarian hyperstimulation syndrome. Curr Health Sci J. 2013;39(3):187-92. [Link]
13. Delvigne A. Epidemiology of OHSS. Reprod biomedic online. 2009;19(1):8-13. [Link] [DOI:10.1016/S1472-6483(10)60040-5]
14. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod update. 2002;8(6):559-77. [Link] [DOI:10.1093/humupd/8.6.559]
15. Mokhtar S, Hassan HA, Mahdy N, Elkhwsky F, Shehata G. Risk factors for primary and secondary female infertility in Alexandria: A hospital based case control study. J Med Res Institute. 2006;27(4):255-61. [Link]
16. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27(2-3):121-8. [Link] [DOI:10.1007/s10815-010-9387-6] [PMID] [PMCID]
17. McCormick B, Thomas M, Maxwell R, Williams D, Aubuchon M. Effects of polycystic ovarian syndrome on in vitro fertilization–embryo transfer outcomes are influenced by body mass index. Fertil steril. 2008;90(6):2304-9. [Link] [DOI:10.1016/j.fertnstert.2007.10.077] [PMID]
18. Fitzmaurice GJ, Boylan C, McClure N. Are pregnancy rates compromised following embryo freezing to prevent OHSS?. Ulster Med J. 2008;77(3):164-7. [Link] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb